Apple has teamed up with genetic testing firm 23andMe to add “spit kit” capabilities to its ResearchKit framework, allowing patients who are participating in clinical trials using iPhone apps to submit their genetic information to the data collected.

The global giant will also release a new open source software framework called CareKit next month that is aimed at extending the capabilities of the ResearchKit platform to help developers build personal apps that allow patients to monitor care plans, medications and symptoms and take a more active role in their healthcare.